论文部分内容阅读
目的 :探讨 型糖尿病病人的糖化血红蛋白 (HBA1 C)与血管性假血友病因子 (v WF)、抗凝血酶 (AT- )的关系。方法 :对 2 5例病人治疗前、后血浆 HBA1 C,v WF及 AT- 进行了测定。结果 :NIDDM病人 HBA1 C正常后 ,v WF显著下降 ,AT- 显著升高但均未达到正常。结论 :NIDDM病人 HBA1 C得到控制后仍应继续进行抗血管病变及抗凝治疗
Objective: To investigate the relationship between glycosylated hemoglobin (HBA1 C) and von Willebrand factor (vWF) and antithrombin (AT-) in type 2 diabetic patients. Methods: The plasma levels of HBA1 C, v WF and AT- in 25 patients before and after treatment were measured. Results: After HBA1 C was normal in NIDDM patients, vWF was significantly decreased and AT- was significantly increased but none of them reached the normal level. Conclusion: Anti-vascular disease and anticoagulant therapy should be continued after HBA1 C is controlled in NIDDM patients